Please login to the form below

Not currently logged in
Email:
Password:

New Zealand

This page shows the latest New Zealand news and features for those working in and with pharma, biotech and healthcare.

Standard steroid improves recovery of critically-ill COVID-19 patients

Standard steroid improves recovery of critically-ill COVID-19 patients

The patient population included participants of mixed ethnicities in the UK, Ireland, Australia, the US, the Netherlands, New Zealand, Canada and France.

Latest news

  • Merck expands partnership with Zymeworks for multispecific antibodies Merck expands partnership with Zymeworks for multispecific antibodies

    The new license agreement grants Merck the right to develop additional multispecific antibody candidates using Zymework’s Azymetric and EFECT platforms. ... Chinese pharma BeiGene also owns the rights to Zanidatamab and ZW49 in a number of East Asian

  • Healthcare’s voice revolution Healthcare’s voice revolution

    Given that the pharma industry is prevented from advertising directly to consumers almost everywhere (except the USA and New Zealand), being able to provide support to medication users via voice tech ... task with limited added value, especially when the

  • The business case for patient engagement The business case for patient engagement

    2. Brand recognition pays off. The scope of pharma’s ability to shape brand perception among patients varies around the world, with only the USA and New Zealand permitting ... Digital channels offer pharma companies a new line of communication, to

  • IQVIA and partners set up cancer ‘data hub’ to speed up research IQVIA and partners set up cancer ‘data hub’ to speed up research

    Seven research centres to be rolled out across UK. Health Data Research UK has announced the opening of seven new data hubs, which will aid in the discovery of new medicines ... The study showed that the UK performed worse than Australia, Canada, Denmark,

  • Universal flu vaccine heads for UK trials Universal flu vaccine heads for UK trials

    Most of the time the predictions are good, but sometimes they miss the mark and a new strain emerges and becomes dominant, rendering the vaccination less effective. ... The NHS is braced for a bad flu season this winter, following the worst outbreak in

More from news
Approximately 3 fully matching, plus 67 partially matching documents found.

Latest Intelligence

  • A new era for UK-Japanese scientific research relations A new era for UK-Japanese scientific research relations

    The TPP covers 11 pacific trading nations, including Australia, New Zealand, Canada and Malaysia, valued at 13% of the global economy and more than £110bn of trade in 2019. ... With this in mind, the UK’s importance in the development of new chemical

  • Pharmaceutical social media after Cambridge Analytica Pharmaceutical social media after Cambridge Analytica

    The House of Commons has called for new independent regulation to be funded by a levy on tech companies operating in the UK, in order “.to create a regulatory system for ... prescription-only medicines is illegal outside the United States or New Zealand

  • The pill branding The pill branding

    and New Zealand.

  • Deal Watch table for July 2014 Deal Watch table for July 2014

    635. Zealand Pharma/ Boehringer Ingelheim. R&D collaboration. Peptide discovery collaboration with cardio-metabolic focus. ... 12. All deals are worldwide unless otherwise noted.    Europe, Japan, Canada, Australia and New Zealand.

  • Pharma deals during July 2014 Pharma deals during July 2014

    prohibit Cosmo from competing directly with the new company in the gastrointestinal area in the US. ... In 2014, under this new agreement, Zealand expects to receive payments from its partner of around $7.5m.

More from intelligence
Approximately 0 fully matching, plus 7 partially matching documents found.

Latest appointments

  • Porterhouse announces members of medical advisory group Porterhouse announces members of medical advisory group

    She has a BSc and a MBChB gained from the University of Otago, New Zealand. ... After graduating, Sykes worked in hospitals in the Auckland region of New Zealand for three years across a range of medical specialities.

  • GSK appoints president of global pharmaceuticals GSK appoints president of global pharmaceuticals

    He also brings management experience from Sanofi's operations in the US, Thailand, New Zealand and Australia to the role. ... Luke will bring a strong new voice to the decisions and choices we will have to make for our pharmaceuticals business.

  • Dr Susanne Fiedler takes over as CEO of MSD Germany Dr Susanne Fiedler takes over as CEO of MSD Germany

    based role as managing director of MSD Australia and New Zealand. ... She will officially take on her new role on 1 February, when Quodt moves to a new European level position.

  • Zealand Pharma appoints new CEO Zealand Pharma appoints new CEO

    Britt Meelby Jensen joins from cancer diagnostics firm Dako. Denmark-based Zealand Pharma has appointed Britt Meelby Jensen as its new CEO, effective from January 15, 2015. ... Regarding his departure from the company, Solomon said: "Zealand is entering

  • PharmaVentures increases its Asia-Pacific presence PharmaVentures increases its Asia-Pacific presence

    Aki von Roy will be based in Auckland, New Zealand. Oxford, UK-headquartered advisory firm PharmaVentures has appointed Aki von Roy as an associate based in Auckland, New Zealand.

More from appointments
Approximately 0 fully matching, plus 14 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 17 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Research Partnership

We are the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical...

Latest intelligence

Webinar:
Securing a future for telehealth with immersive market research insights...
Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...
Six ways to improve diversity in clinical trials
Diversity is becoming increasingly important as a focus of clinical trials. This whitepaper gives six approaches that could be implemented to help make diversity a bigger focus on your clinical...